CBS 2019
CBSMD教育中心
English

科学研究

科研文章

荐读文献

Percutaneous Intervention for Concurrent Chronic Total Occlusions in Patients With STEMI: The EXPLORE Trial From Early Pharmacology to Recent Pharmacology Interventions in Acute Coronary Syndromes Cardiovascular Aging and Heart Failure: JACC Review Topic of the Week Myocardial Infarction Risk Stratification With a Single Measurement of High-Sensitivity Troponin I Appropriate Use Criteria and Health Status Outcomes Following Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From the OPEN-CTO Registry Selection of stenting approach for coronary bifurcation lesions Morphine and Cardiovascular Outcomes Among Patients With Non-ST-Segment Elevation Acute Coronary Syndromes Undergoing Coronary Angiography A Test in Context: E/A and E/e' to Assess Diastolic Dysfunction and LV Filling Pressure Percutaneous coronary intervention for coronary bifurcation disease: 11th consensus document from the European Bifurcation Club Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction
|<<... 39 40 41 42 43 44 45 ...>>|

Clinical Case StudyVolume 5, Issue 6, June 2017, Pages 894–898

JOURNAL：Clin Case Rep. Article Link

Successful bailout stenting strategy against lethal coronary dissection involving left main bifurcation

Kubota H, Nomura T, Hori Y et al. Keywords: Bailout stenting; coronary dissection; iatrogenic; left main bifurcation

ABSTRACT

Catheter-induced coronary dissection involving left main bifurcation is a rare complication during cardiac catheterization but can become lethal unless it is treated appropriately. Interventional cardiologists always have to pay attention to the risk of complications related to cardiac catheterization and prepare for determining the best bailout strategy for the situation.
>CBS CBS 2019

> CBS 2019

> CBS 2019 注册

> CBS 2019 会议日程

> CBS 2019 学术征集

> CBS 2019 热点

 CBSMD

> CBSMD 网站注册

> 教育中心

> 荐读文献

> Top 10 阅读文献

> 文献导读
CBS 2019 CBS 2019 主席团 教育中心 科研动态
Copyright ⓒ CBS MD Nanjing China. All rights reserved. 京ICP备16025898号-11
联系我们| Top